desipramine has been researched along with nicotine in 63 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 25 (39.68) | 18.7374 |
1990's | 10 (15.87) | 18.2507 |
2000's | 21 (33.33) | 29.6817 |
2010's | 7 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Bauer, C; Caldwell, L; Kinnier, WJ; Lancaster, J; McMillan, B; Price, CH; Sweetnam, PM | 1 |
Fei, YJ; Ganapathy, V; Kekuda, R; Leibach, FH; Prasad, PD; Wang, H; Wu, X | 1 |
Giacomini, KM; Schaner, ME; Zhang, L | 1 |
Chen, J; Conway, SJ; Ganapathy, V; Huang, W; Leibach, FH; Prasad, PD; Rajan, DP; Seth, P; Wu, X | 1 |
Conway, SJ; Ganapathy, V; George, RL; Huang, W; Leibach, FH; Wang, H; Wu, X | 1 |
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Keserü, GM | 1 |
Caron, G; Ermondi, G | 1 |
Nagashima, R; Nishikawa, T; Tobita, M | 1 |
Dansette, PM; Fontana, E; Poli, SM | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Jia, L; Sun, H | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Giordanetto, F; Leach, AG; Zachariae, U | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chiou, CY; Trzeciakowski, J | 1 |
Chiba, S | 3 |
Keatinge, WR; Torrie, C | 1 |
Barron, KW; Chien, CY; Diana, JN; Heesch, CM; Qian, SF | 1 |
McKay, DB | 1 |
Daniels, AJ; Diliberto, EJ; Reinhard, JF; Viveros, OH | 1 |
Davidson, RK; Dilsauer, SC; Hariharen, M | 1 |
Goodman, FR; Weiss, GB | 1 |
von Euler, US | 1 |
Creech, BJ; Smith, KR | 1 |
Bhagat, B; Friedman, E | 1 |
Barker, JL; Crayton, JW; Nicoll, RA | 1 |
Goodman, FR | 1 |
Kuchii, M; Mori, J; Shibata, S | 1 |
Ross, G | 1 |
Bevan, JA; Su, C | 2 |
Bhattacharya, IC; Goldstein, L; Pfeiffer, CC | 1 |
Persson, NA; von Euler, US | 1 |
Zetler, G | 1 |
Oliverio, A | 1 |
Jones, RS; Olpe, HR; Steinmann, MW | 1 |
Andersson, A; Olsson, S; Tjälve, H | 1 |
Schottenfeld, RS | 1 |
Acosta, S; Au, D; Lutchmansingh, P; McCracken, JT; McGeoy, S; Poland, RE; Que, M | 1 |
Ceña, V; Fernández-Fernández, JM; González-García, C; Izaguirre, V | 1 |
Bizot, JC | 1 |
Boyle, M; Cunningham, C; Jadad, AR; Kim, M; Schachar, R | 1 |
Caboche, J; Girault, JA; Hervé, D; Pagès, C; Valjent, E | 1 |
Bronius, PF; Brueggeman, RJ; Schoffelmeer, AN; van Gaalen, MM; Vanderschuren, LJ | 1 |
Markou, A; Paterson, NE; Semenova, S | 1 |
3 review(s) available for desipramine and nicotine
Article | Year |
---|---|
The role of receptor binding in drug discovery.
Topics: Animals; Drug Design; Humans; Receptors, Drug | 1993 |
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
Treatment of attention-deficit/hyperactivity disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Behavior; Combined Modality Therapy; Desipramine; Dextroamphetamine; Evidence-Based Medicine; Follow-Up Studies; Humans; Imipramine; Methylphenidate; Nicotine; Nicotinic Agonists; Pemoline; Phenylalanine; Placebos; Randomized Controlled Trials as Topic; Safety; Treatment Outcome | 1999 |
60 other study(ies) available for desipramine and nicotine
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta.
Topics: Amino Acid Sequence; Animals; Cloning, Molecular; DNA-Binding Proteins; HeLa Cells; Humans; Hydrogen-Ion Concentration; Molecular Sequence Data; Octamer Transcription Factor-3; Oocytes; Placenta; Protein Conformation; Rats; Transcription Factors; Xenopus laevis | 1998 |
Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa).
Topics: Carrier Proteins; Corticosterone; HeLa Cells; Humans; Membrane Proteins; Midazolam; Organic Cation Transporter 1; Permeability; Recombinant Proteins; Structure-Activity Relationship; Tetraethylammonium Compounds; Transfection | 1998 |
Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.
Topics: Acetylcarnitine; Animals; Biological Transport, Active; Carnitine; Carrier Proteins; Humans; In Situ Hybridization; Kidney; Membrane Proteins; Mice; Myocardium; Organ Specificity; Organic Cation Transport Proteins; Placenta; Rats; RNA, Messenger; Solute Carrier Family 22 Member 5; Tetraethylammonium | 1999 |
Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta.
Topics: Amino Acid Sequence; Animals; Base Sequence; Carnitine; Carrier Proteins; Cloning, Molecular; DNA, Complementary; Humans; Membrane Proteins; Membrane Transport Proteins; Molecular Sequence Data; Organic Cation Transport Proteins; Placenta; Rats; RNA, Messenger; Solute Carrier Proteins; Structure-Activity Relationship; Symporters; Tetraethylammonium; Tissue Distribution | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers.
Topics: Binding Sites; Ether-A-Go-Go Potassium Channels; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Potassium Channel Blockers; Protein Binding; Protein Conformation | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Histamine mediation of nicotine effects on postganglionic sympathetic neuroeffector junctions.
Topics: Acetyl-CoA C-Acetyltransferase; Animals; Autonomic Fibers, Postganglionic; Chlorpheniramine; Desipramine; Dose-Response Relationship, Drug; Histamine; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Neuroeffector Junction; Nicotine; Pineal Gland; Pulmonary Artery; Rabbits; Rats; Sympathetic Nervous System; Tyramine | 1976 |
Pharmacologic analysis of positive chronotropic and inotropic responses to octopamine.
Topics: Alprenolol; Animals; Desipramine; Dogs; Dopamine; Dose-Response Relationship, Drug; Female; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Nicotine; Norepinephrine; Octopamine; Stimulation, Chemical; Tetrodotoxin | 1976 |
Procaine-induced positive chronotropic and inotropic responses of the isolated, blood-perfused dog atrium.
Topics: Acetylcholine; Animals; Atropine; Desipramine; Dogs; Drug Interactions; Female; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Nicotine; Norepinephrine; Procaine; Propranolol; Stimulation, Chemical; Tetrodotoxin; Tyramine | 1977 |
Action of sympathetic nerves of inner and outer muscle of sheep carotid artery, and effect of pressure on nerve distribution.
Topics: Action Potentials; Animals; Carotid Arteries; Cyanides; Desipramine; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Nicotine; Norepinephrine; Pressure; Sheep; Stimulation, Chemical; Vasomotor System | 1976 |
Pharmacological analysis of dopamine action on the isolated dog atrium.
Topics: Alprenolol; Animals; Desipramine; Dogs; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Heart Atria; Heart Rate; In Vitro Techniques; Nicotine; Norepinephrine; Tetrodotoxin; Tyramine | 1975 |
Nicotine-induced skeletal muscle vasodilation is mediated by release of epinephrine from nerve terminals.
Topics: Adrenalectomy; Adrenergic Antagonists; Animals; Blood Vessels; Desipramine; Dogs; Epinephrine; Female; Ganglionic Blockers; Hemodynamics; Hindlimb; Male; Muscles; Nerve Endings; Nicotine; Norepinephrine; Parasympatholytics; Vasodilation | 1990 |
[3H]noradrenaline accumulation in cultured bovine adrenal medullary cells: modulation of accumulation by nicotine.
Topics: Adrenal Medulla; Animals; Catecholamines; Cattle; Cells, Cultured; Desipramine; Hexamethonium Compounds; Nicotine; Norepinephrine; Reserpine; Sympathetic Nervous System | 1989 |
Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Adrenal Medulla; Animals; Calcium; Catecholamines; Cattle; Cell Compartmentation; Cells, Cultured; Desipramine; Digitonin; Drug Interactions; Nicotine; Pyridines; Pyridinium Compounds; Subcellular Fractions; Tetrabenazine; Tyrosine 3-Monooxygenase | 1987 |
Desipramine subsensitizes nicotinic mechanism involved in regulating core temperature.
Topics: Amitriptyline; Animals; Body Temperature Regulation; Brain; Desipramine; Fluoxetine; Light; Lithium; Male; Nicotine; Phenelzine; Rats; Rats, Inbred Strains; Receptors, Nicotinic | 1988 |
Alteration of 5-hydroxytryptamine-14C efflux by nicotine in rat brain area slices.
Topics: Animals; Bicarbonates; Brain; Calcium; Carbon Radioisotopes; Cerebellum; Cerebral Cortex; Corpus Striatum; Desipramine; Hydrazines; Hydroxyindoleacetic Acid; Hypothalamus; Ileum; In Vitro Techniques; Male; Muscle, Smooth; Nicotine; Potassium; Procaine; Rats; Serotonin; Sodium; Sodium Isotopes; Temperature; Time Factors | 1973 |
Effect of drugs on adrenergic nerve terminals.
Topics: Amines; Animals; Antidepressive Agents; Axons; Bretylium Compounds; Desipramine; Guanethidine; In Vitro Techniques; Membranes; Monoamine Oxidase Inhibitors; Nerve Endings; Neurotransmitter Agents; Nicotine; Norepinephrine; Reflex; Reserpine; Sulfhydryl Reagents; Sympathetic Nervous System; Sympatholytics; Synaptic Transmission; Tyramine | 1971 |
Effects of pharmacological agents on the physiological responses of hair discs.
Topics: Acetylcholine; Action Potentials; Alkaloids; Amitriptyline; Animals; Anticonvulsants; Calcium; Catecholamines; Desipramine; Electric Stimulation; Hair; Imipramine; Lobeline; Magnesium; Monoamine Oxidase Inhibitors; Nicotine; Parasympathomimetics; Plants, Medicinal; Plants, Toxic; Potassium; Rats; Reserpine; Sensory Receptor Cells; Serotonin; Skin Physiological Phenomena; Synaptic Transmission; Touch; Veratrum | 1967 |
Uptake of (3H)noradrenaline in the rat heart during increased sympathetic nervous activity associated with cold.
Topics: Angiotensin II; Animals; Cocaine; Cold Temperature; Desipramine; Male; Myocardium; Nicotine; Norepinephrine; Rats; Tritium; Tyramine | 1968 |
Noradrenaline and acetylcholine responses of supraoptic neurosecretory cells.
Topics: Acetylcholine; Adrenergic beta-Antagonists; Alkaloids; Amino Alcohols; Anilides; Animals; Atropine; Carbachol; Cats; Depression, Chemical; Desipramine; Dopamine; Drug Synergism; Hypothalamo-Hypophyseal System; Hypothalamus; Methacholine Compounds; Nerve Endings; Neurosecretion; Nicotine; Norepinephrine; Physostigmine; Serotonin; Sulfonamides | 1971 |
Effects of nicotine on distribution and release of 14C-norepinephrine and 14C-dopamine in rat brain striatum and hypothalamus slices.
Topics: Animals; Calcium; Carbon Radioisotopes; Cerebellum; Cerebral Cortex; Corpus Striatum; Desipramine; Dopamine; Dopamine Antagonists; Hypothalamus; In Vitro Techniques; Kinetics; Male; Nicotine; Norepinephrine; Rats; Sodium | 1974 |
Pharmacological nature of adrenergic innervation in rat aorta.
Topics: Animals; Aorta; Aorta, Thoracic; Autoradiography; Cocaine; Desipramine; Dose-Response Relationship, Drug; Electric Stimulation; Fluorescence; Histocytochemistry; Hydroxydopamines; In Vitro Techniques; Muscle Contraction; Nicotine; Norepinephrine; Rats; Sympathetic Nervous System; Time Factors; Tritium; Tyramine | 1973 |
Effects of intracoronary infusions of acetylcholine and nicotine on the dog heart in vivo.
Topics: Acetylcholine; Animals; Atropine; Blood Pressure; Coronary Vessels; Desipramine; Dogs; Electric Stimulation; Heart; Heart Rate; Injections, Intra-Arterial; Nicotine; Phenoxybenzamine; Sympathetic Nervous System | 1973 |
Uptake of nicotine by the sympathetic nerve terminals in the blood vessel.
Topics: Animals; Aorta; Autonomic Fibers, Postganglionic; Blood Vessels; Cocaine; Desipramine; Extracellular Space; Guanethidine; In Vitro Techniques; Muscle Contraction; Nerve Endings; Nicotine; Norepinephrine; Pulmonary Artery; Rabbits; Sympathetic Nervous System; Time Factors; Tritium | 1972 |
Influence of acute and chronic nicotine administration on EEG reactivity to drugs in rabbits. 2. Psychoactive agents.
Topics: 5-Hydroxytryptophan; Animals; Cerebral Cortex; Chlordiazepoxide; Deanol; Depression, Chemical; Desipramine; Electroencephalography; Injections, Subcutaneous; Male; Nicotine; Rabbits; Stimulation, Chemical; Time Factors | 1970 |
Potentiation of adrenergic cardiovascular effects of two quaternary nicotine analogues by reserpine.
Topics: Animals; Blood Pressure; Cardiovascular System; Cats; Cell Membrane Permeability; Desipramine; Drug Antagonism; Drug Synergism; Heart Rate; Hexamethonium Compounds; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nicotine; Prenylamine; Pyridinium Compounds; Reserpine | 1970 |
Blockade of the nicotine-induced norepinephrine release by cocaine, phenoxybenzamine and desipramine.
Topics: Action Potentials; Animals; Axons; Bretylium Compounds; Cocaine; Desipramine; Electric Stimulation; Guanethidine; Muscle Contraction; Nicotine; Norepinephrine; Phenoxybenzamine; Pulmonary Artery; Rabbits; Reserpine; Tetrodotoxin; Tritium | 1970 |
Cataleptic state and hypothermia in mice, caused by central cholinergic stimulation and antagonized by anticholinergic and antidepressant drugs.
Topics: Amitriptyline; Animals; Antidepressive Agents; Atropine; Catalepsy; Desipramine; Hexamethonium Compounds; Humans; Hypothermia; Imipramine; Male; Mice; Nicotine; Nicotinic Acids; Nitrophenols; Parasympatholytics; Parasympathomimetics; Phosphoric Acids; Pilocarpine; Pralidoxime Compounds; Scopolamine; Tremorine | 1968 |
Analysis of the "anti-fatigue" activity of amphetamine. Role of central adrenergic mechanisms.
Topics: Amphetamine; Animals; Avoidance Learning; Desipramine; Drug Antagonism; Escape Reaction; Fatigue; Methyltyrosines; Mice; Nicotine; Pargyline | 1967 |
The locus coeruleus: actions of psychoactive drugs.
Topics: Action Potentials; Animals; Atropine; Caffeine; Chlorpromazine; Desipramine; Haloperidol; Locus Coeruleus; Male; Neurons; Nicotine; Norepinephrine; Physostigmine; Psychotropic Drugs; Rats; Scopolamine | 1983 |
The uptake of 14C-chloroquine by mouse pancreatic islets in vitro.
Topics: Absorption; Animals; Chloroquine; Chlorpromazine; Desipramine; Glucose; Hydrogen-Ion Concentration; Imipramine; Islets of Langerhans; Lidocaine; Mice; Nicotine; Nitrogen; Ouabain; Quinacrine; Temperature | 1980 |
Clinical trials of pharmacologic treatments in pregnant women--methodologic considerations.
Topics: Bromocriptine; Buprenorphine; Clinical Trials as Topic; Desipramine; Dopamine Agonists; Female; Humans; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Research Design; Substance-Related Disorders | 1995 |
Exposure to threshold doses of nicotine in utero: III. Augmentation of the prolactin and ACTH response to 8-OH DPAT by desipramine treatment is compromised in adult male offspring.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic Uptake Inhibitors; Adrenocorticotropic Hormone; Animals; Desipramine; Drug Synergism; Female; Male; Nicotine; Nicotinic Agonists; Pregnancy; Prenatal Exposure Delayed Effects; Prolactin; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists | 1996 |
Tricyclic antidepressants block cholinergic nicotinic receptors and ATP secretion in bovine chromaffin cells.
Topics: Adenosine Triphosphate; Animals; Antidepressive Agents, Tricyclic; Cattle; Cells, Cultured; Chromaffin Cells; Desipramine; Imipramine; Membrane Potentials; Nicotine; Nicotinic Antagonists; Potassium; Receptors, Nicotinic | 1997 |
Effects of psychoactive drugs on temporal discrimination in rats.
Topics: Animals; Atropine; Clomipramine; Desipramine; Diazepam; Discrimination Learning; Discrimination, Psychological; Haloperidol; Male; Nicotine; Psychotropic Drugs; Rats; Rats, Wistar; Scopolamine | 1997 |
Effectiveness of attention-deficit/hyperactivity treatment and diagnosis methods tested.
Topics: Adult; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Comorbidity; Desipramine; Dextroamphetamine; Drug Therapy, Combination; Female; Humans; Lithium; Male; Methylphenidate; Nicotine; Pemoline; Phenylalanine | 2000 |
Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain.
Topics: Adrenergic Uptake Inhibitors; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Benzazepines; Brain; Caffeine; Central Nervous System Stimulants; Cocaine; Desipramine; Dopamine Antagonists; Dronabinol; Enzyme Activation; Fluoxetine; Immunohistochemistry; Male; Mice; Mitogen-Activated Protein Kinases; Morphine; Muscarinic Antagonists; Neurons; Nicotine; Nicotinic Agonists; Scopolamine; Selective Serotonin Reuptake Inhibitors | 2004 |
Behavioral disinhibition requires dopamine receptor activation.
Topics: Amphetamine; Animals; Behavior, Animal; Benzazepines; Cocaine; Desipramine; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Nicotine; Piperazines; Rats; Rats, Wistar; Receptors, Dopamine; Serotonin | 2006 |
The effects of chronic versus acute desipramine on nicotine withdrawal and nicotine self-administration in the rat.
Topics: Animals; Antidepressive Agents, Tricyclic; Conditioning, Operant; Depression; Desipramine; Food; Infusion Pumps, Implantable; Injections, Intravenous; Nicotine; Nicotinic Agonists; Rats; Reward; Self Administration; Self Stimulation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |